screening kpi data summary factsheets may 2019 – issue 7 · screening kpi data summary...
TRANSCRIPT
Screening KPI data summary factsheets May 2019 – Issue 7
Screening KPI data summary factsheets: May 2019 – Issue 7
2
About Public Health England
Public Health England exists to protect and improve the nation’s health and wellbeing,
and reduce health inequalities. We do this through world-leading science, knowledge and
intelligence, advocacy, partnerships and the delivery of specialist public health services.
We are an executive agency of the Department of Health and Social Care, and a distinct
delivery organisation with operational autonomy. We provide government, local government,
the NHS, Parliament, industry and the public with evidence-based professional, scientific
and delivery expertise and support.
Public Health England, Wellington House, 133-155 Waterloo Road, London SE1 8UG
Tel: 020 7654 8000 www.gov.uk/phe
Twitter: @PHE_uk Facebook: www.facebook.com/PublicHealthEngland
About PHE screening
Screening identifies apparently healthy people who may be at increased risk of a
disease or condition, enabling earlier treatment or informed decisions. National
population screening programmes are implemented in the NHS on the advice of the UK
National Screening Committee (UK NSC), which makes independent, evidence-based
recommendations to ministers in the 4 UK countries. PHE advises the government and
the NHS so England has safe, high quality screening programmes that reflect the best
available evidence and the UK NSC recommendations. PHE also develops standards
and provides specific services that help the local NHS implement and run screening
services consistently across the country.
www.gov.uk/phe/screening Twitter: @PHE_Screening Blog: phescreening.blog.gov.uk
For queries relating to this document, please contact: [email protected]
© Crown copyright 2019
You may re-use this information (excluding logos) free of charge in any format or
medium, under the terms of the Open Government Licence v3.0. To view this licence,
visit OGL. Where we have identified any third-party copyright information you will need
to obtain permission from the copyright holders concerned.
Published May 2019
PHE publications PHE supports the UN
gateway number: GW-397 Sustainable Development Goals
Screening KPI data summary factsheets: May 2019 – Issue 7
3
Introduction
This high-level report presents the key performance indicator (KPI) data for all 11
national screening programmes. The NHS screening programmes selected the KPIs to
define consistent performance measures for a selection of public health priorities. The
KPIs give a high-level overview of the quality of screening programmes at key points on
the screening pathway. They contribute to the quality assurance of screening
programmes but are not, in themselves, sufficient to quality assure or performance
manage screening services.
Screening KPIs are contained within the Section 7a agreements between the
Department of Health and Social Care (DHSC) and NHS England and in the Public
Health Outcomes Framework (PHOF).
This report will focus on the most recent data collected with national comparisons to
quarterly performance since 2015 to 2016 where available.
Please note this issue of the factsheet is not re-published if the corresponding KPI data
is updated
Further information
This report should be read in conjunction with the full KPI datasets for Q2 and Q3 2018
to 2019, and the KPI reporting data definitions for 2018 to 2019.
For all information about KPIs, including submission dates, templates and previous
quarterly and annual data publications, please see our national data reporting page.
Information about screening standards and service specifications are available for each
programme.
Please contact the screening helpdesk if you would like further information on
screening KPIs: [email protected].
Screening KPI data summary factsheets: May 2019 – Issue 7
4
Summary dashboard
KPICurrent
quarter
% previous
quarter
% current
quarter
Significant
change
Acceptable
threshold
Achievable
thresholdRAG
ID1 Q3 2018/19 99.6 99.7 95.0 99.0
ID2 Q3 2018/19 85.6 88.4 70.0 90.0
ID3 Q3 2018/19 99.6 99.7 95.0 99.0
ID4 Q3 2018/19 99.6 99.7 95.0 99.0
FA1 Q3 2018/19 98.2 98.2 97.0 100
FA2 Q2 2018/19 99.1 98.9 90.0 95.0
ST1 Q3 2018/19 99.6 99.7 95.0 99.0
ST2 Q3 2018/19 57.0 58.9 50.0 75.0
ST3 Q3 2018/19 97.4 97.8 95.0 99.0
NB1 Q3 2018/19 97.9 97.6 95.0 99.0
NB2 Q3 2018/19 2.1 2.1 2.0 1.0
NB4 Q3 2018/19 90.0 87.8 95.0 99.0
NH1 Q3 2018/19 98.8 98.7 98.0 99.5
NH2 Q3 2018/19 91.6 89.8 90.0 95.0
NP1 Q3 2018/19 96.3 96.5 95.0 99.5
NP2 Q3 2018/19 65.7 66.7 95.0 100
DE1 Q3 2018/19 83.0 83.1 75.0 85.0
DE2 Q3 2018/19 94.8 98.2 70.0 95.0
DE3 Q3 2018/19 78.5 77.8 80.0 -
AA2 Q3 2018/19 42.6 61.6 - 56.0 64.0
AA3 Q3 2018/19 91.6 92.5 85.0 95.0
AA4 Q3 2018/19 93.4 92.9 85.0 95.0
BCS1 Q3 2018/19 59.4 58.2 52.0 60.0
BCS2 Q2 2018/19 59.2 59.5 - -
BS1 Q3 2018/19 67.4 67.7 70.0 80.0
BS2 Q3 2018/19 87.0 86.6 90.0 100
CS1 Q3 2018/19 69.1 69.1 80.0 -
CS2 Q3 2018/19 76.2 76.1 80.0 -
Screening KPI data summary factsheets: May 2019 – Issue 7
5
Summary dashboard explained The dashboard displays:
• the current quarterly time period
• the national performance of the current quarter and previous quarter
• any significant change (displayed as arrows) from the previous to current quarter
• the acceptable and achievable thresholds
• the red, amber, green (RAG) rating
The thresholds are defined as follows:
The acceptable threshold is the lowest level of performance which screening services
are expected to attain. All screening services should exceed the acceptable threshold
and agree service improvement plans to meet the achievable threshold. Screening
services not meeting the acceptable threshold are expected to put in place recovery
plans to deliver rapid and sustained improvement
The achievable threshold is the level at which the screening service is likely to be
running optimally. All screening services should aspire to attain and maintain
performance at or above this level.
The RAG rating compares the current quarterly performance to the thresholds. If the
performance is below the acceptable threshold is it rated red, if performance is equal to
or above the acceptable threshold but below the achievable threshold it is rated amber,
and if performance is equal to or above the achievable threshold it is rated green. KPIs
DE3, CS1 and CS2 only have the acceptable threshold; therefore only red or green is
displayed. BCS2 has no thresholds therefore no RAG rating is applied.
The upwards or downwards arrows displayed represent where there has been a
significant increase or decrease in national performance (uses the Wilson Score
method), or a horizontal arrow showing no significant change. KPI AA2 is an annual
indicator, with quarterly data cumulative from Q1 to the current quarter; therefore no
significance arrow is applied.
Screening KPI data summary factsheets: May 2019 – Issue 7
6
Index of KPIs: Antenatal and newborn
KPI code
KPI name
ID1 Antenatal infectious disease screening – HIV coverage
ID2
Antenatal infectious disease screening – timely assessment of women with hepatitis B
ID3 Antenatal infectious disease screening – hepatitis B coverage
ID4 Antenatal infectious disease screening – syphilis coverage
FA1 Fetal anomaly screening – completion of laboratory request forms
FA2 Fetal anomaly screening – ultrasound coverage
FA3 Fetal anomaly screening – coverage for Down’s, Edwards’ and Patau’s syndromes
ST1 Antenatal sickle cell and thalassaemia screening – coverage
ST2 Antenatal sickle cell and thalassaemia screening – timeliness of test
ST3 Antenatal sickle cell and thalassaemia screening – completion of FOQ
ST4a Antenatal sickle cell and thalassaemia screening – timely offer of prenatal diagnosis (PND) to women at risk of having an affected infant
ST4b Antenatal sickle cell and thalassaemia screening – timely offer of prenatal diagnosis (PND) to couples at risk of having an affected infant
NB1 Newborn blood spot screening – coverage (CCG responsibility at birth)
NB2 Newborn blood spot screening – avoidable repeat tests
NB4 Newborn blood spot screening – coverage (movers in)
NH1 Newborn hearing screening – coverage
NH2
Newborn hearing – time from screening outcome to attendance at an audiological assessment appointment
NP1 Newborn and infant physical examination – coverage (newborn)
NP2
Newborn and infant physical examination – timely assessment of developmental dysplasia of the hip (DDH)
Screening KPI data summary factsheets: May 2019 – Issue 7
7
Index of KPIs: Young person and adult
KPI code
KPI name
DE1 Diabetic eye screening – uptake of routine digital screening event
DE2 Diabetic eye screening – results issued within 3 weeks of routine digital screening
DE3 Diabetic eye screening – timely assessment for R3A screen positive
AA2 Abdominal aortic aneurysm screening – coverage of initial screen
AA3 Abdominal aortic aneurysm screening – coverage of annual surveillance screen
AA4 Abdominal aortic aneurysm screening – coverage of quarterly surveillance screen
BCS1 Bowel cancer screening – uptake
BCS2 Bowel cancer screening – coverage
BS1 Breast screening – uptake
BS2 Breast screening – screening round length
CS1 Cervical screening – coverage (under 50)
CS2 Cervical screening – coverage (50 and above)
Screening KPI data summary factsheets: May 2019 – Issue 7
8
Infectious diseases in pregnancy (IDPS) programme
KPI ID1: HIV coverage
99.0 99.0 98.8 99.1 99.3 99.4 99.5 99.5 99.5 99.6 99.6 99.6 99.7 99.6 99.7
88
90
92
94
96
98
100
Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4
2015 to 2016 2016 to 2017 2017 to 2018 2018 to 2019
Covera
ge (
%)
National trend data
Acceptable (95%)* Achievable (99%)*
*Thresholds changed in 2016 to 2017
99.7 99.9 99.7 99.7 99.7
0
20
40
60
80
100
England London Midlands& East
North South
Covera
ge (
%)
Quarter 3 performance
National performance of ID1 in Q3 remained above the
achievable threshold at 99.7%
145 out of 147 screening providers met the acceptable
threshold of 95.0% (2 providers did not submit)
141 out of 147 screening providers reached the achievable
threshold of 99.0%
KPI ID1
Reporting period: Q3 2018 to 2019
England
- numerator = 170,175
- denominator = 170,625
- performance = 99.7%
Completeness of data: 98.6%
KPI ID1 description
The proportion of pregnant women eligible for HIV screening for whom a confirmed screening result is available at the day of report
Reported by: Maternity service
Back to index
Screening KPI data summary factsheets: May 2019 – Issue 7
9
Infectious diseases in pregnancy (IDPS) programme
KPI ID2: Timely assessment of women with hepatitis B
KPI ID2
Reporting period: Q3 2018 to 2019
England
- numerator = 206
- denominator = 233
- performance = 88.4%
Completeness of data: 99.3%
73.4 73.3 73.3 73.681.0
76.481.3 82.8
85.981.0
83.6 85.4 84.5 85.6 88.4
40
50
60
70
80
90
100
Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4
2015 to 2016 2016 to 2017 2017 to 2018 2018 to 2019
Seen f
or
hep B
(%
)
National trend data
Acceptable (70%) Achievable (90%)
88.4 88.1 88.1 84.496.4
0
20
40
60
80
100
England London Midlands& East
North South
Seen f
or
hep B
(%
)
Quarter 3 performance
KPI ID2 description
The proportion of pregnant women who are hepatitis B positive attending for specialist assessment within 6 weeks of the positive result being reported to maternity services
Reported by: Maternity service
ID2 is a small number KPI, therefore the data should be
interpreted with caution
Since 2016 to 2017, ID2 counts only women with hepatitis B
who are either newly diagnosed or known positive with high
infectivity markers
Back to index
National performance of ID2 reached its highest recorded
level in Q3 at 88.4%
Screening KPI data summary factsheets: May 2019 – Issue 7
10
Infectious diseases in pregnancy (IDPS) programme
KPI ID3: Hepatitis B coverage
99.7 99.6 99.7
88
90
92
94
96
98
100
Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4
2015 to 2016 2016 to 2017 2017 to 2018 2018 to 2019
Hepatitis B
covera
ge (
%)
National trend data
Acceptable (95%) Achievable (99%)
KPI ID3 description
The proportion of pregnant women eligible for hepatitis B screening for whom a confirmed screening result is available at the day of report
Reported by: Maternity service
Back to index
ID3 is a newly published KPI from 2018 to 2019. National
performance in Q3 was 99.7%, above the achievable threshold
145 out of 147 screening providers met the acceptable
threshold of 95.0% (2 providers did not submit)
141 out of 147 screening providers reached the achievable
threshold of 99.0%
KPI ID3
Reporting period: Q3 2018 to 2019
England
- numerator = 170,185
- denominator = 170,623
- performance = 99.7%
Completeness of data: 98.6%
99.7 99.9 99.7 99.7 99.7
0
20
40
60
80
100
England London Midlands& East
North South
Hepatitis B
covera
ge (
%)
Quarter 3 performance
Screening KPI data summary factsheets: May 2019 – Issue 7
11
Infectious diseases in pregnancy (IDPS) programme
KPI ID4: Syphilis coverage
99.6 99.6 99.7
88
90
92
94
96
98
100
Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4
2015 to 2016 2016 to 2017 2017 to 2018 2018 to 2019
Syphili
s c
overa
ge (
%)
National trend data
Acceptable (95%) Achievable (99%)
99.7 99.9 99.7 99.7 99.7
0
20
40
60
80
100
England London Midlands& East
North South
Syphili
s c
overa
ge (
%)
Quarter 3 performance
KPI ID4 description
The proportion of pregnant women eligible for syphilis screening for whom a confirmed screening result is available at the day of report
Reported by: Maternity service
Back to index
ID4 is a newly published KPI from 2018 to 2019. National
performance in Q3 was 99.7%, above the achievable threshold
145 out of 147 screening providers met the acceptable
threshold of 95.0% (2 providers did not submit)
141 out of 147 screening providers reached the achievable
threshold of 99.0%
KPI ID4
Reporting period: Q3 2018 to 2019
England
- numerator = 170,193
- denominator = 170,626
- performance = 99.7%
Completeness of data: 98.6%
Screening KPI data summary factsheets: May 2019 – Issue 7
12
Fetal anomaly screening programme (FASP)
KPI FA1: Completion of laboratory request forms
KPI FA1
Reporting period: Q3 2018 to 2019 England
- numerator = 120,181
- denominator = 122,352
- performance = 98.2%
Completeness of data: 99.3%
96.397.0 97.0 96.9 97.2 97.3 97.5 97.4 97.6 97.3 97.6 97.9 98.0 98.2 98.2
88
90
92
94
96
98
100
Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4
2015 to 2016 2016 to 2017 2017 to 2018 2018 to 2019
Com
ple
tion (
%)
National trend data
Acceptable (97%) Achievable (100%)
98.2 99.1 98.1 98.0 97.8
0
20
40
60
80
100
England London Midlands& East
North South
Com
ple
tion (
%)
Quarter 3 performance
National performance of FA1 in Q3 remained at its highest ever
level at 98.2%
123 out of 147 screening providers met the acceptable
threshold of 97.0% (1 provider did not submit)
9 out of 147 screening providers reached the achievable
threshold of 100%
KPI FA1 description
The proportion of laboratory request forms including complete data prior to screening analysis,
submitted to the laboratory within the recommended timeframe of 10+0
to 20+0
weeks’ gestation
Reported by: Maternity service
Back to index
Screening KPI data summary factsheets: May 2019 – Issue 7
13
Fetal anomaly screening programme (FASP)
KPI FA2: Ultrasound coverage
98.8 98.9 98.9 98.8 99.1 98.9
88
90
92
94
96
98
100
Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4
2015 to 2016 2016 to 2017 2017 to 2018 2018 to 2019
Ultra
sound c
overa
ge (
%)
National trend data
Acceptable (90%) Achievable (95%)
KPI FA2
Reporting period: Q2 2018 to 2019 England
- numerator = 134,808
- denominator = 136,308
- performance = 98.9%
Completeness of data: 93.9%
KPI FA2 description
The proportion of pregnant women eligible for fetal anomaly ultrasound screening who are tested leading to a conclusive result within the designated timescale
Reported by: Maternity service
Back to index
National performance of FA2 in Q2 was above the achievable
threshold at 98.9%, with 137 out of 147 providers submitting data
133 out of 147 screening providers met the achievable
threshold of 95.0% (9 providers did not submit)
FA2 was introduced in 2016 to 2017 and is collected 2
quarters in arrears
98.9 99.1 98.9 98.3 99.4
0
20
40
60
80
100
England London Midlands& East
North SouthUltra
sound c
overa
ge (
%)
Quarter 2 performance
Screening KPI data summary factsheets: May 2019 – Issue 7
14
Fetal anomaly screening programme (FASP)
KPI FA3: Coverage for Down’s syndrome, Edwards’ syndrome and Patau’s syndrome
Back to index
KPI FA3 description
The proportion of pregnant women eligible for first trimester combined screening for T21 and T18/T13 for whom a conclusive screening result is available at the day of report
Reported by: Maternity service
FA3 is a new KPI introduced in 2018 to 2019. New KPIs are
not published in the first year of data collection. This time is
used to improve the data quality and completeness, by
revising the definition, adding clarity and / or setting
thresholds as required. After this time PHE Screening will
review the data with the aim of publishing it nationally from
the following year
Screening KPI data summary factsheets: May 2019 – Issue 7
15
Sickle cell and thalassaemia (SCT) screening programme
KPI ST1: Coverage
99.1 99.1 98.8 98.7 99.1 99.3 99.3 99.2 99.5 99.5 99.6 99.6 99.6 99.6 99.7
88
90
92
94
96
98
100
Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4
2015 to 2016 2016 to 2017 2017 to 2018 2018 to 2019
Covera
ge (
%)
National trend data
Acceptable (95%) Achievable (99%)
National performance of ST1 in Q3 remained at its highest ever
level recorded for this KPI at 99.7%
145 out of 147 screening providers met the acceptable
threshold of 95.0% (2 providers did not submit)
138 out of 147 screening providers reached the achievable
threshold of 99.0%
KPI ST1
Reporting period: Q3 2018 to 2019
England
- numerator = 170,087
- denominator = 170,656
- performance = 99.7%
Completeness of data: 98.6%
KPI ST1 description
The proportion of pregnant women eligible for antenatal sickle cell and thalassaemia screening for whom a screening result is available at the day of report
Reported by: Maternity service
Back to index
99.7 99.8 99.6 99.7 99.5
0
20
40
60
80
100
England London Midlands& East
North South
Covera
ge (
%)
Quarter 3 performance
Screening KPI data summary factsheets: May 2019 – Issue 7
16
Sickle cell and thalassaemia (SCT) screening programme
KPI ST2: Timeliness of test
58.9 50.8 59.6 62.6 60.8
0
20
40
60
80
100
England London Midlands& East
North South
Tim
elin
ess o
f te
st (%
)
Quarter 3 performance
50.9 51.7 53.3 50.1 50.9 53.1 54.8 53.9 54.8 56.7 57.6 54.5 56.0 57.0 58.9
0
20
40
60
80
100
Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4
2015 to 2016 2016 to 2017 2017 to 2018 2018 to 2019
Tim
elin
ess o
f te
st (%
)
National trend data
Acceptable (50%) Achievable (75%)
National performance of ST2 in Q3 was 58.9%, the highest ever
level recorded for this KPI
122 out of 147 screening providers met the acceptable
threshold of 50.0% (3 providers did not submit)
21 out of 147 screening providers reached the achievable
threshold of 75.0%
KPI ST2
Reporting period: Q3 2018 to 2019
England
- numerator = 100,395
- denominator = 170,495
- performance = 58.9%
Completeness of data: 98.0%
KPI ST2 description
The proportion of women having antenatal sickle cell and thalassaemia screening for whom a screening result is available by 10 weeks + 0 days gestation
Reported by: Maternity service
Back to index
Screening KPI data summary factsheets: May 2019 – Issue 7
17
Sickle cell and thalassaemia (SCT) screening programme
KPI ST3: Completion of FOQ
96.6 97.0 97.0 96.9 97.0 97.1 97.4 97.6 97.8 97.5 97.5 97.6 97.8 97.4 97.8
88
90
92
94
96
98
100
Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4
2015 to 2016 2016 to 2017 2017 to 2018 2018 to 2019
Com
ple
tion o
f F
OQ
(%
)
National trend data
Acceptable (95%) Achievable (99%)
National performance of ST3 in Q3 was 97.8%, slightly higher
compared to the previous quarter
127 out of 147 screening providers met the acceptable
threshold of 95.0% (4 providers did not submit)
58 out of 147 screening providers reached the
achievable threshold of 99.0%
KPI ST3 description
The proportion of antenatal sickle cell and thalassaemia samples submitted to the laboratory accompanied by a completed FOQ
Reported by: Maternity service
KPI ST3
Reporting period: Q3 2018 to 2019
England
- numerator = 165,952
- denominator = 169,729
- performance = 97.8%
Completeness of data: 97.3%
Back to index
97.8 97.9 97.7 97.8 97.7
0
20
40
60
80
100
England London Midlands& East
North South
Com
ple
tion o
f F
OQ
(%
)
Quarter 3 performance
Screening KPI data summary factsheets: May 2019 – Issue 7
18
Sickle cell and thalassaemia (SCT) screening programme
KPI ST4a: Timely offer of prenatal diagnosis (PND) to women at risk of having an affected infant
Back to index
ST4a is a new KPI introduced in 2018 to 2019. New KPIs
are not published in the first year of data collection. This
time is used to improve the data quality and completeness,
by revising the definition, adding clarity and / or setting
thresholds as required. After this time PHE Screening will
review the data with the aim of publishing it from the
following year
KPI ST4a description
The proportion of at risk women offered PND by 12 weeks + 0 days gestation Reported by: Maternity service
Screening KPI data summary factsheets: May 2019 – Issue 7
19
Sickle cell and thalassaemia (SCT) screening programme
KPI ST4b: Timely offer of prenatal diagnosis (PND) to couples at risk of having an affected infant
Back to index
ST4b is a new KPI introduced in 2018 to 2019. New KPIs
are not published in the first year of data collection. This
time is used to improve the data quality and completeness,
by revising the definition, adding clarity and / or setting
thresholds as required. After this time PHE Screening will
review the data with the aim of publishing it from the
following year
KPI ST4b description
The proportion of at risk couples offered PND by 12 weeks + 0 days gestation Reported by: Maternity service
Screening KPI data summary factsheets: May 2019 – Issue 7
20
Newborn blood spot (NBS) screening programme
KPI NB1: Coverage (CCG responsibility at birth)
KPI NB1
Reporting period: Q3 2018 to 2019
England
- numerator = 144,544
- denominator = 148,173
- performance = 97.6%
Completeness of data: 98.5%
95.6 95.894.7
96.2 96.6 97.1 96.595.5 96.1
97.396.4 97.0
97.7 97.9 97.6
88
90
92
94
96
98
100
Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4
2015 to 2016 2016 to 2017 2017 to 2018 2018 to 2019
Covera
ge (
%)
National trend data
Acceptable (95%) Achievable (99%)*
*Achieveable threshold changed in 2017 to 2018
National performance of NB1 in Q3 was 97.6%, slightly lower
compared to the previous quarter
173 out of 195 CCGs met the acceptable threshold of
95.0% (3 CCGs did not submit)
68 out of 195 CCGs reached the achievable threshold of
99.0%
KPI NB1 description
The proportion of babies registered within the clinical commissioning group (CCG) both at birth and on the last day of the reporting period who are eligible for newborn blood spot (NBS)
screening and have a conclusive result recorded on the child health information system (CHIS) at less than or equal to 17 days of age
Reported by: CCG
Back to index
97.6 96.8 97.5 97.6 98.1
0
20
40
60
80
100
England London Midlands& East
North South
Covera
ge (
%)
Quarter 3 performance
Screening KPI data summary factsheets: May 2019 – Issue 7
21
Newborn blood spot (NBS) screening programme
KPI NB2: Avoidable repeat tests
4.4
3.4 3.4 3.6
3.1 2.8 2.9 2.92.6 2.4 2.4 2.4 2.3 2.1 2.1
0
1
2
3
4
5
Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4
2015 to 2016 2016 to 2017 2017 to 2018 2018 to 2019
Avoid
able
repeat
tests
(%
)
National trend data
Acceptable (2%) Achievable (1%)*
*Achievable threshold changed in 2017 to 2018
2.1 2.0 1.92.6
1.9
0
1
2
3
England London Midlands& East
North South
Aoiv
dable
repeat
tests
(%
)
Quarter 3 performance
National consensus guidelines for blood spot testing were introduced in April 2015; avoidable repeats increased in 2015 to
2016 but has subsequently reduced
NB2 is a reverse polarity KPI, where a lower performance is better. National performance of NB2 in Q3 remained at its
lowest ever level at 2.1%
81 out of 147 screening providers met the acceptable
threshold of 2.0% (1 provider did not submit)
KPI NB2
Reporting period: Q3 2018 to 2019
England
- numerator = 3,405
- denominator = 160,971
- performance = 2.1%
Completeness of data: 99.3%
KPI NB2 description
The proportion of first blood spot samples that require repeating due to an avoidable failure in the sampling process
Reported by: Maternity service
Back to index
Screening KPI data summary factsheets: May 2019 – Issue 7
22
Newborn blood spot (NBS) screening programme
KPI NB4: Coverage (movers in)
88.9 88.586.5 85.3
88.591.0
88.9 89.9 90.2 90.087.8
70
75
80
85
90
95
100
Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4
2015 to 2016 2016 to 2017 2017 to 2018 2018 to 2019
Covera
ge (
movers
in)
(%)
National trend data
Acceptable (95%) Achievable (99%)*
*Achievable threshold changed in 2017 to 2018
87.8 88.5 91.3 85.1 83.8
0
20
40
60
80
100
England London Midlands& East
North South
Covera
ge (
movers
in)
(%)
Quarter 3 performance
2016 to 2017 was the first year of data publication for NB4
National performance of NB4 decreased in Q3 to 87.8% (3
out of 195 CCGs did not submit)
NB4 is a small number KPI, therefore the data should be
interpreted with caution
KPI NB4
Reporting period: Q3 2018 to 2019
England
- numerator = 13,375
- denominator = 15,225
- performance = 87.8%
Completeness of data: 98.5%
KPI NB4 description
The proportion of all babies eligible for newborn blood spot (NBS) screening who have changed responsible CCG in the first year of life; or have moved in from another UK country or
abroad, and have a conclusive result recorded on the CHIS at less than or equal to 21 calendar days of notifying the CHRD of movement in
Reported by: CCG
Back to index
Screening KPI data summary factsheets: May 2019 – Issue 7
23
Newborn hearing screening programme (NHSP)
KPI NH1: Coverage
98.4 98.0 98.0 98.4 98.5 98.3 98.2 98.7 98.6 98.5 98.4 98.6 98.9 98.8 98.7
88
90
92
94
96
98
100
Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4
2015 to 2016 2016 to 2017 2017 to 2018 2018 to 2019
Covera
ge (
%)
National trend data
Acceptable (98%)* Achievable (99.5%)
*Threshold changed in 2016 to 2017, and 2018 to 2019
98.7 98.6 99.0 98.4 99.0
0
20
40
60
80
100
England London Midlands& East
North South
Covera
ge (
%)
Quarter 3 performance
National performance of NH1 in Q3 remained high at 98.7%
90 out of 109 screening providers met the new acceptable
threshold of 98.0%
29 out of 109 screening providers reached the achievable
threshold of 99.5%
KPI NH1
Reporting period: Q3 2018 to 2019
England
- numerator = 153,344
- denominator = 155,286
- performance = 98.7%
Completeness of data: 100%
KPI NH1 description
The proportion of babies eligible for newborn hearing screening for whom the screening process is complete by 4 weeks corrected age (hospital programmes: well babies, NICU
babies) or by 5 weeks corrected age (community programmes: well babies) Reported by: Local NHSP site
Back to index
Screening KPI data summary factsheets: May 2019 – Issue 7
24
Newborn hearing screening programme (NHSP)
KPI NH2: Time from screening outcome to attendance at an audiological assessment appointment
86.2 87.3 86.9 88.390.1 88.5 87.3
89.2 89.2 89.687.8 88.1 89.6
91.689.8
70
75
80
85
90
95
100
Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4
2015 to 2016 2016 to 2017 2017 to 2018 2018 to 2019
Tim
e to a
ssessm
ent (%
)
National trend data
Acceptable (90%) Achievable (95%)*
89.8 93.6 92.1 86.1 90.5
0
20
40
60
80
100
England London Midlands& East
North South
Tim
e to a
ssessm
ent (%
)
Quarter 3 performance
National performance of NH2 in Q3 was 89.8%, a slight
decrease compared with the previous quarter
67 out of 109 screening providers met the acceptable
threshold of 90.0%
NH2 is a small number KPI, therefore the data should be
interpreted with caution
KPI NH2
Reporting period: Q3 2018 to 2019
England
- numerator = 3,203
- denominator = 3,567
- performance = 89.8%
Completeness of data: 100%
KPI NH2 description
The proportion of babies with a no clear response result in one or both ears or other result that require an immediate onward referral for audiological assessment who receive audiological
assessment within the required timescale
Reported by: Local NHSP site
Back to index
Screening KPI data summary factsheets: May 2019 – Issue 7
25
Newborn and infant physical examination (NIPE) screening programme
KPI NP1: Coverage (newborn)
94.692.9
94.4 94.493.0 93.3 93.2 93.8 94.5 95.3 95.5 95.8 96.1 96.3 96.5
80
85
90
95
100
Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4
2015 to 2016 2016 to 2017 2017 to 2018 2018 to 2019
Covera
ge (
new
born
) (%
)
National trend data
Acceptable (95%) Achievable (99.5%)
96.5 95.9 96.5 96.5 97.0
0
20
40
60
80
100
England London Midlands& East
North South
Covera
ge (
new
born
) (%
)
Quarter 3 performance
We currently recommend not to use NIPE data as a
performance measure because of issues with data
quality
KPI NP1
Reporting period: Q3 2018 to 2019 England
- numerator = 150,829
- denominator = 156,322
- performance = 96.5%
Completeness of data: 99.3%
KPI NP1 description
The proportion of babies eligible for the newborn physical examination who are tested for all 4 components (3 components in female infants) of the newborn examination within 72 hours of
birth
Reported by: Maternity service
Back to index
Screening KPI data summary factsheets: May 2019 – Issue 7
26
Newborn and infant physical examination (NIPE) screening programme
KPI NP2: Timely assessment of developmental dysplasia of the hip
31.721.9
35.548.6
15.0
43.650.4
56.4
35.854.2
63.4 64.157.6
65.7 66.7
0
20
40
60
80
100
Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4
2015 to 2016 2016 to 2017 2017 to 2018 2018 to 2019
Tim
ely
assessm
ent of
DD
H
(%)
National trend data
Acceptable (95%) Achievable (100%)
66.775.8 72.1
59.7 67.5
0
20
40
60
80
100
England London Midlands& East
North South
Tim
ely
assessm
ent of
D
DH
(%
)
Quarter 3 performance
We currently recommend not to use NIPE data as a
performance measure because of issues with data
quality. NP2 is a small number KPI.
KPI NP2
Reporting period: Q3 2018 to 2019 England
- numerator = 287
- denominator = 430
- performance = 66.7%
Completeness of data: 99.3%
KPI NP2 description
The proportion of babies who have a positive screening test on newborn physical examination and undergo assessment by specialist hip ultrasound within 2 weeks of age
Reported by: Maternity service
Back to index
Screening KPI data summary factsheets: May 2019 – Issue 7
27
Diabetic eye screening (DES) programme
KPI DE1: Uptake of routine digital screening event
82.8 82.9 83.6 83.0 82.5 82.2 82.1 82.2 82.3 82.2 82.2 82.7 83.0 83.0 83.1
50
60
70
80
90
100
Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4
2015 to 2016 2016 to 2017 2017 to 2018 2018 to 2019
Upta
ke o
f R
DS
(%
)
National trend data
Acceptable (75%)* Achievable (85%)*
*Thresholds changed in 2017 to 2018
83.1 84.8 82.8 82.1 83.8
0
20
40
60
80
100
England London Midlands& East
North South
Upta
ke o
f R
DS
(%
)
Quarter 3 performance
KPI DE1
Reporting period: Q3 2018 to 2019
England
- numerator = 2,323,138
- denominator = 2,794,814
- performance = 83.1%
Completeness of data: 100%
KPI DE1 description
The proportion of those offered routine digital screening who attend a digital screening event where images are captured
Reported by: Local DES service
Back to index
National performance of DE1 in Q3 was 83.1%, the highest it has
been for 3 years
61 out of 62 screening providers met the acceptable
threshold of 75.0%
21 out of 62 screening providers reached the
achievable threshold of 85.0%
Screening KPI data summary factsheets: May 2019 – Issue 7
28
Diabetic eye screening (DES) programme
KPI DE2: Results issued within 3 weeks of routine digital screening, digital surveillance or slit lamp biomicroscopy
97.5 97.1 95.8 96.2 97.3 98.395.7 94.6
91.893.9
96.4 95.2 94.5 94.898.2
60
70
80
90
100
Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4
2015 to 2016 2016 to 2017 2017 to 2018 2018 to 2019
Results w
ithin
3 w
eeks (
%)
National trend data
Acceptable (70%) Achievable (95%)
98.2 99.8 97.7 97.9 98.0
0
20
40
60
80
100
England London Midlands& East
North SouthResults w
ithin
3 w
eeks (
%)
Quarter 3 performance
KPI DE2
Reporting period: Q3 2018 to 2019
England
- numerator = 650,481
- denominator = 662,657
- performance = 98.2%
Completeness of data:100%
KPI DE2 description
The proportion of subjects attending for diabetic eye screening, digital surveillance or slit lamp biomicroscopy to whom results were issued within 3 weeks of the screening event
Reported by: Local DES service
Back to index
National performance of DE2 in Q3 was 98.2%, the highest it
has been for 2 years
61 out of 62 screening providers met the
acceptable threshold of 70.0%
55 out of 62 screening providers reached the
achievable threshold of 95.0%
Screening KPI data summary factsheets: May 2019 – Issue 7
29
Diabetic eye screening (DES) programme
KPI DE3: Timely assessment for R3A screen positive
80.3 80.2 77.9 80.276.0 74.8 75.8 75.0 75.5 74.1 76.0 78.2
74.978.5 77.8
50
60
70
80
90
100
Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4
2015 to 2016 2016 to 2017 2017 to 2018 2018 to 2019
Tim
ely
assessm
ent fo
r R
3A
+ve (
%)
National trend data
Acceptable (80%)
77.8 79.9 78.9 77.2 75.9
0
20
40
60
80
100
England London Midlands& East
North South
Tim
ely
assessm
ent fo
r R
3A
+ve (
%)
Quarter 3 performance
KPI DE3
Reporting period: Q3 2018 to 2019
England
- numerator = 1,790
- denominator = 2,300
- performance = 77.8%
Completeness of data: 100%
KPI DE3 description
The proportion of screen positive subjects with referred proliferative (R3A) diabetic retinopathy attending for assessment within 6 weeks of their screening event from all diabetic eye
screening pathways
Reported by: Local DES service
Back to index
National performance of DE3 in Q3 was 77.8%, below the
acceptable threshold of 80.0%
33 out of 62 screening providers met the acceptable
threshold of 80.0%
DE3 is a small number KPI, therefore the data should be
interpreted with caution
Screening KPI data summary factsheets: May 2019 – Issue 7
30
Abdominal aortic aneurysm (AAA) screening programme
KPI AA2: Coverage of initial screen
23.5
44.0
63.0
78.7
23.9
43.9
62.1
77.6
23.2
42.6
61.6
0
20
40
60
80
100
Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4
2015 to 2016 2016 to 2017 2017 to 2018 2018 to 2019
Covera
ge o
f in
itia
l scre
en (
%)
National trend dataAcceptable (%) Achievable (%)
Q1 Q2 Q3 Q4
Acceptable ≥ 18.0% ≥ 38.0% ≥ 56.0% ≥ 75.0%
Achievable ≥ 21.0% ≥ 42.0% ≥ 64.0% ≥ 85.0%
2016 to 2017 was the first year of data publication for AA2. AA2 is an annual indicator, quarterly figures are cumulative from
Q1 to the current quarter
The performance thresholds for AA2 increase on a quarterly basis in order to best reflect the nature of the local screening
service call to screening
National performance of AA2 in Q3 was above the acceptable threshold at 61.6%. 32 out of 39 screening
providers met the acceptable threshold of 56.0%
KPI AA2
Reporting period: Q3 2018 to 2019
England
- numerator = 180,821
- denominator = 293,622
- performance = 61.6%
Completeness of data: 100%
KPI AA2 description
The proportion of men eligible for abdominal aortic aneurysm screening who are conclusively tested
Reported by: Local AAA screening service
61.69.9
61.4 61.070.9
0
20
40
60
80
100
England London Midlands& East
North South
Covera
ge o
f in
itia
lscre
en (
%)
Quarter 3 performance
Back to index
Screening KPI data summary factsheets: May 2019 – Issue 7
31
Abdominal aortic aneurysm (AAA) screening programme
KPI AA3: Coverage of annual surveillance screen
2016 to 2017 was the first year of data publication for AA3
National performance of AA3 in Q3 was 92.5%, above the
acceptable threshold but below the achievable threshold
36 out of 39 providers met the acceptable threshold of 85.0%
and 10 providers met the achievable threshold of 95.0%
KPI AA3
Reporting period: Q3 2018 to 2019
England
- numerator = 2,879
- denominator = 3,112
- performance = 92.5%
Completeness of data: 100%
KPI AA3 description
The proportion of annual surveillance appointments due where there is a conclusive test within 6 weeks of the due date
Reported by: Local AAA screening service
90.5 91.3 91.2 91.3 90.992.5 92.5 92.5 91.9 91.6 92.5
80
85
90
95
100
Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4
2015 to 2016 2016 to 2017 2017 to 2018 2018 to 2019
Covera
ge o
f annual surv
eill
ance
scre
en (
%)
National trend data
Acceptable (85%) Achievable (95%)
92.5 88.5 93.1 92.5 92.8
0
20
40
60
80
100
England London Midlands& East
North South
Covera
ge o
f annual
surv
eill
ance s
cre
en (
%)
Quarter 3 performance
Back to index
Screening KPI data summary factsheets: May 2019 – Issue 7
32
Abdominal aortic aneurysm (AAA) screening programme
KPI AA4: Coverage of quarterly surveillance screen
KPI AA4
Reporting period: Q3 2018 to 2019
England
- numerator = 2,263
- denominator = 2,436
- performance = 92.9%
Completeness of data: 100%
2016 to 2017 was the first year of data publication for AA4
National performance of AA4 in Q3 was 92.9% above the
acceptable threshold but below the achievable threshold
36 out of 39 providers met the acceptable threshold of 85.0%
and 16 providers met the achievable threshold of 95.0%
KPI AA4 description
The proportion of quarterly surveillance appointments due where there is a conclusive test within 4 weeks of the due date
Reported by: Local AAA screening service
93.291.6
93.2 92.6 91.893.4 93.5
91.2 91.393.4 92.9
80
85
90
95
100
Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4
2015 to 2016 2016 to 2017 2017 to 2018 2018 to 2019
Covera
ge o
f quart
erly
surv
eill
ance s
cre
en (
%)
National trend data
Acceptable (85%) Achievable (95%)
92.981.4
93.1 94.7 93.6
0
20
40
60
80
100
England London Midlands& East
North South
Covera
ge o
f quart
erly
surv
eill
ance s
cre
en (
%)
Quarter 3 performance
Back to index
Screening KPI data summary factsheets: May 2019 – Issue 7
33
Bowel cancer screening programme (BCSP)
KPI BCS1: Uptake
KPI BCS1
Reporting period: Q3 2018 to 2019
England
- numerator = 675,593
- denominator = 1,161,597
- performance = 58.2%
Completeness of data: 100%
2017 to 2018 was the first year of data publication for BCS1
57 out of 64 screening providers met the acceptable threshold of 52.0%
National performance of BCS1 in Q3 was 58.2%, above the
acceptable threshold and below the achievable threshold
KPI BCS1 description
The proportion of eligible men and women aged 60 to 74 years invited to participate in bowel cancer screening who adequately participate
Reported by: Local screening centre (also by CCG in the data publication)
58.2 60.146.9
57.7 60.7 60.4
0
20
40
60
80
100
England Eastern London MidlandsAnd North
West
NorthEast
Southern
Upta
ke (
%)
Quarter 3 performance
Back to index
58.0 56.1 53.758.7 58.9 59.4 58.2
0
20
40
60
80
100
Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4
2015 to 2016 2016 to 2017 2017 to 2018 2018 to 2019
Upta
ke (
%)
National trend data
Acceptable (52%) Achievable (60%)
Screening KPI data summary factsheets: May 2019 – Issue 7
34
Bowel cancer screening programme (BCSP)
KPI BCS2: Coverage
KPI BCS2
Reporting period: Q2 2018 to 2019
England
- numerator = 4,835,726
- denominator = 8,128,008
- performance = 59.5%
Completeness of data: 100%
KPI BCS2 description
The proportion of eligible men and women aged 60 to 74 years invited for screening who have had an adequate faecal occult blood test (FOBt) screening result in the previous 30 months
Reported by: Local authority
58.8 58.9 58.9 58.9 59.2 59.5
0
20
40
60
80
100
Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4
2015 to 2016 2016 to 2017 2017 to 2018 2018 to 2019
Covera
ge (
%)
National trend data
59.5 50.6 59.7 60.3 62.0
0
20
40
60
80
100
England London Midlands &East
North South
Covera
ge (
%)
Quarter 2 performance
Back to index
2017 to 2018 was the first year of data publication for BCS2
and is available 6 months in arrears
Coverage ranged from 50.6% in London to 62.0% in the South
National performance of BCS at Q2 was 59.5%. There are
no thresholds set for this KPI.
Screening KPI data summary factsheets: May 2019 – Issue 7
35
Breast screening programme (BSP)
KPI BS1: Uptake
KPI BS1
Reporting period: Q3 2018 to 2019 England
- numerator = 410,020
- denominator = 605,373
- performance = 67.7%
Completeness of data: 100%
KPI BS1 description
The proportion of eligible women invited who attend for screening Reported by: Local screening service
2017 to 2018 was the first year of data publication for BS1.
Quarterly data is considered provisional, annual data is definitive
National performance of BS1 in Q3 was 67.7%, below the
acceptable threshold of 70.0%
31 out of 78 screening providers reached the acceptable
threshold; no providers met the achievable threshold
67.2 67.1 66.8 67.3 67.9 67.4 67.7
0
20
40
60
80
100
Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4
2015 to 2016 2016 to 2017 2017 to 2018 2018 to 2019
Upta
ke (
%)
National trend data
Acceptable (70%) Achievable (80%)
67.757.5
68.4 68.9 70.4
0
20
40
60
80
100
England London Midlands& East
North South
Upta
ke (
%)
Quarter 3 performance
Back to index
Screening KPI data summary factsheets: May 2019 – Issue 7
36
Breast screening programme (BSP)
KPI BS2: Screening round length
2017 to 2018 was the first year of data publication for BS2
National performance of BS2 in Q3 was 86.6%, below the
acceptable threshold
59 out of 78 screening providers reached the acceptable
threshold; no providers met the achievable threshold
KPI BS2
Reporting period: Q3 2018 to 2019 England
- numerator = 397,516
- denominator = 458,902
- performance = 86.6%
Completeness of data: 100%
KPI BS2 description
The proportion of eligible women whose date of first offered appointment is within 36 months of their previous screen. Women being screened for the first time will not be included in screening
round length statistics
Reported by: Local screening service
90.6 89.6 90.3 91.9 87.5 87.0 86.6
0
20
40
60
80
100
Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4
2015 to 2016 2016 to 2017 2017 to 2018 2018 to 2019
Scre
enin
g r
ound length
(%
)
National trend data
Acceptable (90%) Achievable (100%)
Back to index
86.6 90.2 85.9 88.0 84.6
0
20
40
60
80
100
England London Midlands& East
North South
Scre
enin
g r
ound length
Quarter 3 performance
(%)
Screening KPI data summary factsheets: May 2019 – Issue 7
37
Cervical screening programme (CSP)
KPI CS1: Coverage (under 50 years)
KPI CS1
Reporting period: Q3 2018 to 2019
England
- numerator = 6,978,549
- denominator = 10,100,015
- performance = 69.1%
Completeness of data: 100%
KPI CS1 description
The proportion of women in the resident population eligible for cervical screening aged 25 to 49 years at end of period reported who were screened adequately within the previous 3.5
years
Reported by: CCG
Back to index
69.7 69.1 68.6 69.4 69.6 69.1 69.1
0
20
40
60
80
100
Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4
2015 to 2016 2016 to 2017 2017 to 2018 2018 to 2019
Covera
ge u
nder
50 y
ears
(%
)
National trend data
Acceptable (80%)
2017 to 2018 was the first year of data publication for CS1
National performance of CS1 in Q3 was below the
acceptable threshold at 69.1%
One out of 195 CCGs met the acceptable threshold of
80.0%
69.1 61.4 70.5 71.5 71.6
0
20
40
60
80
100
England London Midlands& East
North South
Covera
ge u
nder
50 y
ears
Quarter 3 performance
(%)
Screening KPI data summary factsheets: May 2019 – Issue 7
38
Cervical screening programme (CSP)
KPI CS2: Coverage (50 years and above)
KPI CS2
Reporting period: Q3 2018 to 2019
England
- numerator = 3,746,897
- denominator = 4,925,823
- performance = 76.1%
Completeness of data: 100%
Back to index
2017 to 2018 was the first year of data publication for CS2
National performance of CS2 in Q3 was below the
acceptable threshold at 76.1%
4 out of 195 CCGs met the acceptable threshold of
80.0%
KPI CS2 description
The proportion of women in the resident population eligible for cervical screening aged 50 to 64 years at end of reported period who were screened adequately within the previous 5.5 years
Reported by: CCG
77.1 76.7 76.3 76.3 76.4 76.2 76.1
0
20
40
60
80
100
Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4
2015 to 2016 2016 to 2017 2017 to 2018 2018 to 2019Covera
ge 5
0 y
ears
and o
ver
National trend data
Acceptable (80%)
(%)
76.1 73.8 76.6 76.2 76.5
0
20
40
60
80
100
England London Midlands& East
North South
Covera
ge 5
0 y
ears
and
over
(%)
Quarter 3 performance